Hellier I, Dereure O, Segondy M, Guillot B, Baldet P, Guilhou J J
Department of Dermatology-Phlebology, University Hospital of Montpellier, Hôpital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier Cedex 5, France.
Eur J Dermatol. 2001 May-Jun;11(3):203-8.
Primary cutaneous CD30+ anaplastic large cell lymphoma (ALCL) is a rare subset of cutaneous lymphoma, with a much better prognosis than its nodal counterpart. The pathogenesis of both nodal and primary cutaneous CD30+ ALCL is largely unknown but experimental data support the hypothesis that the Epstein-Barr virus could play a role in the nodal subset.
To evaluate the involvement of Epstein-Barr Virus (EBV) in primary cutaneous CD30+ ALCL by searching for both nucleic acids and EBV proteins in cutaneous lesions.
Two University Hospitals in Southern France (secondary referral hospitals).
Eight consecutive patients with typical primary cutaneous CD30+ anaplastic large cell lymphoma were studied.
Search for the presence of DNA, RNA and EBV proteins in cutaneous lesions by PCR, in situ hybridization and immunohistochemistry.
EBV DNA and RNA was identified in only one lesion of primary cutaneous CD30+ ALCL and in none of the normal adjacent skin samples. In situ hybridization and immunohistological studies were consistently negative in all samples.
These results do not support an early role of EBV in the oncogenetic pathogenesis of primary cutaneous CD30+ ALCL.
原发性皮肤CD30+间变性大细胞淋巴瘤(ALCL)是皮肤淋巴瘤中罕见的一个亚型,其预后远优于淋巴结型。淋巴结型和原发性皮肤CD30+ ALCL的发病机制大多未知,但实验数据支持爱泼斯坦-巴尔病毒(EBV)可能在淋巴结型中起作用这一假说。
通过在皮肤病变中寻找核酸和EBV蛋白,评估EBV在原发性皮肤CD30+ ALCL中的参与情况。
法国南部的两家大学医院(二级转诊医院)。
对8例连续的典型原发性皮肤CD30+间变性大细胞淋巴瘤患者进行研究。
通过聚合酶链反应(PCR)、原位杂交和免疫组织化学检测皮肤病变中DNA、RNA和EBV蛋白的存在情况。
仅在1例原发性皮肤CD30+ ALCL病变中鉴定出EBV DNA和RNA,而在所有正常相邻皮肤样本中均未检出。原位杂交和免疫组织学研究在所有样本中均呈持续阴性。
这些结果不支持EBV在原发性皮肤CD30+ ALCL肿瘤发生机制中起早期作用。